Share
News
-
27 November 2008 /Prices and reimbursement
Reassessment of reimbursement status for 5 combination products in ATC groups C07, C08 and C09
The Danish Medicines Agency has assessed the question of the future reimbursement status for five combination products in ATC groups C07, C08 and C09 on the basis of updated information about prices and consumption of these medicinal products.
-
21 November 2008 /Prices and reimbursement
Consultation responses on the future reimbursement status of medicinal products for cardiovascular diseases
The Reimbursement Committee’s additional recommendation concerning the future reimbursement status of medicinal products for cardiovascular diseases in ATC groups C02, C03, C07, C08 and C09 (antihypertensives) was submitted for consultation with 19 September 2008 as the consultation deadline
-
20 November 2008 /Authorisation and supervision
Control of Eprex®
The Danish Medicines Agency has determined the activity of seven different batches of Eprex®. Eprex® is used for the treatment of anaemia in case of chronic renal failure.
-
20 November 2008 /Side effects and trials
New information about cardiovascular adverse reactions from the use of NSAID
A Danish study has provided information about the cardiovascular safety of using pain-killing medicinal products of the NSAID type. The study is a well-designed pharmacoepidemiological study based on, among other things, information from the Danish Register of Medicinal Product Statistics, and it was published on 5 November 2008 at the website of the journal Clinical Pharmacology & Therapeutics.
-
10 November 2008 /Authorisation and supervision
Sale or delivery of advanced therapy medicinal products on 30 December 2008
The regulation on advanced therapy medicinal products (Regulation (EC) no. 1394/2007 of 13 November 2007), which enters into force on 30 December 2008, contains a transitional provision for medicinal products sold or delivered legally in the EU on this date.
-
10 November 2008 /Authorisation and supervision
Control of medicinal product labelling (fall 2008)
The Danish Medicines Agency has controlled different elements of the labelling in the below medicinal products, due to, among other things, complaints and reports submitted to the Danish Patient Safety Database.
-
10 November 2008 /About us
Digitisation of the Danish Medicines Agency
On 30 October 2008, the Danish Finance Committee approved the Danish Medicines Agency's contract with IBM about the digitisation programme DAHLIA.
